Skip to content

Effect of Cannabis on Simulated and Actual Driving in Healthy Subjects

Effect of Cannabis on Simulated and Actual Driving in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01118364
Enrollment
20
Registered
2010-05-06
Start date
2010-05-31
Completion date
2011-12-31
Last updated
2014-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Social circumstances

Brief summary

Assess the effect of cigarette smoking of tobacco with or without addition of resin cannabis on driving performance in healthy volunteers in simulated driving in Marseille and Toulouse, and in real world driving to Bordeaux. Multicenter Study of phase 1, randomized, double-blind, cross plan, carried out in healthy male volunteers.

Detailed description

* To compare performance data driving with the data self-assessed on the ability to drive, and the level of sleepiness and fatigue * To measure the effects of distractive task on driving performance, consisting of a conversation with co-driver of the real or simulated vehicle (a series of difficult questions involving reflection) * To validate the (known) effects of cannabis * To adapt equipment and standardize methods for the pharmacological studies evaluating other types of substances having an impact on driving (antihistamines, antidepressants, antiparkinsonian ...) and other populations of subjects (men versus women, young versus elderly, healthy versus sick ...) * To compare data obtained under conditions of simulated driving and actual driving situation, under identical experimental conditions (volunteers, narcotic substance, experimental) and measure the degree of ecological validity of the simulation of driving

Interventions

OTHERCannabis

a cigarette tobacco trade mark Drum with the addition of 250 mg of cannabis resin with 8% of D9THC (20 mg per cigarette)45 minutes before simulating or real driving

OTHERtobacco

a cigarette tobacco trade mark Drum 45 minutes before simulating or real driving

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
25 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Weight +/- 10% of ideal weight * Tobacco smoker moderate * Having already smoked of the cannabis (less 1 time per month) * Not consuming in a way exaggerated by some coffee, tea or cola * Not having acute or chronic pathologies * Normal electrocardiogram * Not taking a drug interfering with the study * Not presenting disorder of sleeping * Having a driving license for at least 3 years and driving more 3000 km per year * Normal acuteness or corrected visual acuteness and normal vision of colors * Reachable and available during the study * No nausea or vomit during using of a driving simulator * Having a national insurance scheme * Volunteer

Exclusion criteria

* Women * Weight deviating of 10% of ideal weight * Consuming moreover 5 cup of caffeine drinks * Drinking alcohol regularly * Acute or chronic pathologies interfering with the study * Abnormal electrocardiogram * Asthmatic * Dependence present or spent in a psychotropic substance * Presenting an anxious or depressive syndrome * Circadian typology (Horne et Ostberg) * Positive control in the cannabis in urines the day of the balance assessment of inclusion * Positive control in alcohol the day of the balance assessment of inclusion * Participating in another clinical study * Having collected an upper total amount of compensations allowances * Deprived of freedom further to a court or administrative order * Risk of not observance * Duration average of sleep of 3 nights previous every session lower than 80 % of the average duration of sleep which the volunteer thinks of needing to be in shape

Design outcomes

Primary

MeasureTime frameDescription
Line crossing1 yearsMeasurement of inappropriate crossing of the limits of track in real or simulated driving

Secondary

MeasureTime frameDescription
Weaving1 yearsMeasure of the deviation of the lateral position of the vehicle on the real or simulated road
Evaluation of sleepiness and fatigue1 years
Evaluation of fitness to drive1 years
Evaluation of fitness to drive during work distraction1 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026